Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
The American Journal of Sports Medicine|September 27, 2025
Autologous Cell Injections for Knee Osteoarthritis Display Greater Responsiveness Than Allogenic Cellular Products and Corticosteroids in a Sex-Dependent MannerKenneth Mautner, Jarred M Kaiser, Blake Boggess, et al.Journal of Proteomics|April 6, 2013
MRI-compatible pipeline for three-dimensional MALDI imaging mass spectrometry using PAXgene fixationJanina Oetjen, Michaela Aichler, Dennis Trede, et al.Frontiers in Pain Research (Lausanne, Switzerland)|June 26, 2025
Sleep hygiene linked to patient-reported outcomes & objective sleep measures prior to upper extremity orthopaedic surgeryNicholas A Giordano, Tatiana Getz, Michael Gottschalk, et al.Science Translational Medicine|July 5, 2023
Measuring anti-islet autoimmunity in mouse and human by profiling peripheral blood antigen-specific CD4 T cellsSiddhartha Sharma, Xuqian Tan, Josh Boyer, et al.Brain : a Journal of Neurology|December 18, 2024
Loss of glymphatic homeostasis in heart failureMarios Kritsilis, Lotte Vanherle, Marko Rosenholm, et al.American Journal of Medical Genetics. Part A|June 25, 2004
Biochemical diagnosis of Antley-Bixler syndrome by steroid analysisCedric Shackleton, Josep Marcos, Ewa M Malunowicz, et al.Journal of Imaging Informatics in Medicine|March 11, 2026
The Emory Knee Radiograph (MRKR) DatasetBrandon J Price, Judy Gichoya, Mohammadreza Chavoshi, et al.Diabetologia|April 8, 2016
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trialStephen E Gitelman, Peter A Gottlieb, Eric I Felner, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2024
Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet VasculatureAnne Costanzo, Don Clarke, Marie Holt, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trialStephen E Gitelman, Peter A Gottlieb, Mark R Rigby, et al.Pageof 6